MCL

PACE/State of FL - Blood diversion as a mechanism to lower blood culture contamination rates.

In this episode of “Lab Medicine Rounds,” Justin Kreuter, M.D., sits down with Medhat Askar, M.D., Ph.D., MSHPE, FRCPath, Professor of Pathology, Texas A&M College of Medicine, and Director of Clinical Services, National Marrow Donor Program (NMDP)/BeTheMatch. Listen as they discuss a very important topic this holiday season, the gift of organ donation.

Ed Garber spent months in physical and neurological decline while a cohort of care providers and specialists searched for the root cause of his symptoms. That search for answers ended after testing by Mayo Clinic Laboratories gave them the confirmatory diagnosis they needed.

In this month's "Hot Topic," Melissa Snyder, Ph.D., co-director of the antibody immunology laboratory at Mayo Clinic, discusses celiac disease and the role of diagnostic testing algorithms.

This list includes updates posted to mayocliniclabs.com during the month of November.

In this episode of “Lab Medicine Rounds,” Justin Kreuter, M.D., sits down with David Murray, M.D., Ph.D., assistant professor of laboratory medicine and pathology, and clinical biochemist in the Protein Immunology Laboratory at Mayo Clinic, to discuss Multiple Myeloma testing.

In this episode of the "Leveraging the Laboratory" podcast, host Jane Hermansen, outreach manager at Mayo Clinic Laboratories, discusses courier options and logistics with outreach colleagues Brianne Newton and Ellen Dijkman Dulkes. They highlight what needs to be considered when choosing a courier service and how to leverage the courier partnership so it adds value to your outreach lab.

Linda Hasadsri, M.D., Ph.D., explains carrier screening at Mayo Clinic Laboratories. Using targeted genotyping, our three focused panels evaluate genes associated with cystic fibrosis, spinal muscular atrophy, and hemoglobinopathies, to provide clear answers on reproductive risks and to guide decision-making.

Utilizing testing capabilities of two separate laboratory facilities, Mayo Clinic Laboratories’ new serotonin release assay (SRA) is a gold-standard test supported by decades of clinical hematopathologic experience and advanced mass spectrometry testing.

Rondell Graham, M.B.B.S., describes Mayo Clinic Laboratories' new assay for gastrointestinal stromal tumors, or GIST. The panel covers multiple mutations, to better inform diagnosis and treatment options.

Since overcoming a life-threatening diagnosis five years ago, Jim Smith has embraced life. But each time he travels to Mayo Clinic for follow-up laboratory testing, a well of emotions rises up to remind him of life’s fragility. Thankfully, through streamlined, accurate testing and top-notch clinical care, those feelings are generally short-lived.

In this month's "Hot Topic," Kevin Halling, M.D., Ph.D., discusses new next generation sequencing testing for various tumor types and the rationale for the enhancements that were made; reviews gene additions that are now available in each of the panels; and briefly speaks about the work that was done to validate cytology specimens for use in the subpanels.

Due to the Thanksgiving holiday (recognized on Thursday, November 24th), Mayo Clinic Laboratories' specimen pickup and delivery schedules will be altered. To ensure that your specimen vitality and turnaround times are not affected, plan ahead.